First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease Johannes Lammer, MD, Marc.

Slides:

Advertisements

Similar presentations

Superficial Femoral Artery Recanalization with Self-expanding Nitinol Stents: Long-term Follow-up Results M. Ferreira, L. Lanziotti, M. Monteiro, G.

Advertisements

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication Saskia.

Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease Marc Husmann, MD,

Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.

Heart failure is associated with reduced patency after endovascular intervention for symptomatic peripheral arterial disease Andrew J. Meltzer, MD, Gautam.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Endovascular treatment of internal iliac artery obstructive disease

Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.

Validation of a new simple questionnaire to “estimate ambulation capacity by history” (EACH) in patients with claudication Nafi Ouedraogo, MD, Guillaume.

Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease Gustavo S. Oderich, MD, Luke.

Steven T. W. van Haelst, MD, Stefanie M. O. Peeters Weem, MD, Frans L

Stenting of femoropopliteal lesions using interwoven nitinol stents

A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients Philip P. Goodney,

Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.

Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease

Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required Brian Tiu, MD, Michael Shih,

Arne Gerhard Schwindt, MD, Giuseppe Panuccio, MD, Konstantinos P

Louis L. Nguyen, MD, MBA, MPH Journal of Vascular Surgery

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects) William R. Hiatt,

Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia Francesco A. Aiello, MD, Asad A.

Collateral artery from arteriovenous malformation of the rectum in a patient with peripheral artery disease Hirotomo Uchiyama, MD, Reiji Hattori, MD,

Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self- expanding stent graft versus prosthetic femoral-popliteal bypass in the.

Changing pattern of surgical revascularization for critical limb ischemia over 12 years: Endovascular vs open bypass surgery Toshifumi Kudo, MD, PhD,

Depression is associated with worse patency and recurrent leg symptoms after lower extremity revascularization Gregory S. Cherr, MD, Jiping Wang, MD,

Changing demographics in patients with vascular disease

Steven T. W. van Haelst, MD, Stefanie M. O. Peeters Weem, MD, Frans L

Results of heparin-bonded ePTFE-covered stents for chronic occlusive superficial femoral artery disease Mare M.A. Lensvelt, MD, Wilbert M. Fritschy,

Open versus endovascular treatment of subclavian artery atherosclerotic disease George C. Galyfos, MD, PhD, Ioannis Kakisis, MD, PhD, Chrisostomos Maltezos,

Surgical revascularization versus endovascular therapy for chronic mesenteric ischemia: A comparative experience Marvin D. Atkins, MD, Christopher J.

Christopher J. Smolock, MD, Javier E

Clinical efficacy of concomitant tibial interventions associated with superficial femoral artery interventions in critical limb ischemia Christopher.

Virendra I. Patel, MD, Mark F. Conrad, MD, Christopher J

Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery.

The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries Jenny J. Lee, MD,

Open versus endovascular revascularization for chronic mesenteric ischemia: Risk- stratified outcomes Gustavo S. Oderich, MD, Thomas C. Bower, MD, Timothy.

Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions Osamu Iida, MD, Shinsuke Nanto, MD, Masaaki Uematsu,

Benign superior vena cava syndrome: Stenting is now the first line of treatment Adnan Z. Rizvi, MD, Manju Kalra, MBBS, Haraldur Bjarnason, MD, Thomas.

The EXercise versus Angioplasty in Claudication Trial (EXACT): Reasons for recruitment failure and the implications for research into and treatment of.

Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery Yoshimitsu.

Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease Christopher J. Smolock, MD, Javier.

Patrick A. Stone, MD, John E. Campbell, MD, Karinna H

Inhibition of experimental neointimal hyperplasia and neoatherosclerosis by local, stent- mediated delivery of everolimus Hugh Q. Zhao, PhD, Alexander.

The walking impairment questionnaire: An effective tool to assess the effect of treatment in patients with intermittent claudication Saskia P.A. Nicolaï,

The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé.

Outcome of drug-eluting balloon angioplasty versus endarterectomy in common femoral artery occlusive disease Tzu-Ting Kuo, MD, Po-Lin Chen, MD, Chun-Yang.

Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: A propensity-matched.

Todd R. Vogel, MD, MPH, Robin L. Kruse, PhD

Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease Robert W. Chang, MD, Philip P. Goodney,

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive.

Soma Brahmanandam, MD, MPH, Eric L. Ding, ScD, Michael S

Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss Mark G. Davies, MD, PhD, Wael E. Saad, MD, Eric.

Regarding “Incidence and clinical significance of peripheral embolization during percutaneous interventions involving the superficial femoral artery”

Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial femoral artery Russell C. Lam,

Mark A. Farber, MD, Robert R. Mendes, MD Journal of Vascular Surgery

Secondary interventions following endovascular abdominal aortic aneurysm repair using current endografts. A EUROSTAR report Roel Hobo, MSc, Jacob Buth,

Donald T. Baril, MD, Luke K. Marone, MD, Justine Kim, Michael R

Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD

Early results of stent-grafting to treat diffuse aortoiliac occlusive disease Eva M Rzucidlo, MD, Richard J Powell, MD, Robert M Zwolak, MD, PhD, Mark.

Efficacious use of nitinol stents in the femoral and popliteal arteries Todd R Vogel, MD, Larry E Shindelman, MD, Gary B Nackman, MD, Alan M Graham, MD

Results of second-time angioplasty and stenting for femoropopliteal occlusive disease and factors affecting outcomes William P. Robinson, MD, Louis L.

The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease—Decision analysis Brian Nolan, MD,

Endovascular interventions for TASC II D femoropopliteal lesions

Emily Spangler, Robert W. Chang, Philip P. Goodney

Results of a single center vascular screening and education program

Association of clinical attributes and treadmill walking performance in patients with claudication due to peripheral artery disease Eric P. Brass, MD,

Thigh claudication due to profunda femoris artery occlusion

PS232. Long-Term Effects of Everolimus-Eluting Self-Expanding Stent Implantation in an Experimental Model of Peripheral Vascular Intervention Hugh Zhao,

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

Presentation transcript:

First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease Johannes Lammer, MD, Marc Bosiers, MD, Thomas Zeller, MD, Martin Schillinger, MD, Els Boone, MSc, Margo J. Zaugg, BSN, Patrick Verta, MD, Lei Peng, MSc, Xingyu Gao, MSc, Lewis B. Schwartz, MD Journal of Vascular Surgery Volume 54, Issue 2, Pages 394-401 (August 2011) DOI: 10.1016/j.jvs.2011.01.047 Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 1 The Dynalink-E self-expanding everolimus-eluting stent. Journal of Vascular Surgery 2011 54, 394-401DOI: (10.1016/j.jvs.2011.01.047) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 2 Clinical results of the Superficial Femoral Artery Treatment with Drug-Eluting Stents (STRIDES) trial as assessed by Rutherford-Becker clinical category (RB). The number of patients evaluated at each interval is shown in parentheses. Journal of Vascular Surgery 2011 54, 394-401DOI: (10.1016/j.jvs.2011.01.047) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 3 Improvement in ambulation following endovascular intervention in the Superficial Femoral Artery Treatment with Drug-Eluting Stents (STRIDES) trial. Patients' ability to ambulate was measured at prespecified time intervals by the Walking Improvement Questionnaire (WIQ). The figure shows, at each interval of study, the percentage of patients that were able to ambulate the stated distances. Journal of Vascular Surgery 2011 54, 394-401DOI: (10.1016/j.jvs.2011.01.047) Copyright © 2011 Society for Vascular Surgery Terms and Conditions

Fig 4 Freedom from target lesion revascularization (solid line) and primary patency (dashed line) in the Superficial Femoral Artery Treatment with Drug-Eluting Stents (STRIDES) trial. Journal of Vascular Surgery 2011 54, 394-401DOI: (10.1016/j.jvs.2011.01.047) Copyright © 2011 Society for Vascular Surgery Terms and Conditions